| Company Name | Stock Symbol | Valuation (B USD) | Funding Stage | Total Funding Raised | Annual Revenue | Profitability | Business Model | Key Products/Services | Core AI Focus | Market Potential |
|---|---|---|---|---|---|---|---|---|---|---|
| Anduril Industries | N/A | 8.5 | Series E | $2.3B | N/A | Unprofitable | B2G (Govt) | AI-powered defense systems, drones | Autonomous Surveillance, AI-Powered Drones | High |
| Moderna | MRNA | 100 | IPO (2018) | $5.2B | $20B | Profitable | B2B (Pharma) | AI-powered mRNA vaccine research | AI in Drug Discovery & Biotech | High |